journal article·2025-02

Rejuvenation Modulation of Nucleus Pulposus Progenitor Cells Reverses Senescence‐Associated Intervertebral Disc Degeneration

Da‐wang Zhao, Jing Zhang, Chen Chen, Weiyi Sun, Ying Liu, Maosen Han, Yulin Zhang, Zhipeng Fu, Chongdeng Shi, Xiaotian Zhao, Zhenmei Yang, Chunwei Tang, Kun Zhao, Danqing Zhu, Yuankai Zhang, Lei Cheng, Xinyi Jiang

Advanced Materials· Volume 37· Issue 7
Publisher page

Abstract

Abstract The decreased regeneration potential of aging nucleus pulposus resident progenitor cells (NPPCs) fails to resist intervertebral disc degeneration (IVDD), and strategies to remodel the regeneration capacity of senescent NPPC are urgently needed. A decrease in Klotho gene expression in NPPCs of both old mice and humans exacerbates the impaired regenerative functionality of NPPC. Here, an NPPC‐targeted lipid thymine nanoparticle (NT‐LNP) is reported for the in situ manipulation of the regenerative repair potential of NPPCs, restoration of degenerated nucleus pulposus tissue, and mitigation of IVDD. Specifically, the results showed that the in‐house customized lipid nanoparticles efficiently introduced Klotho circular ribonucleic acid (circRNA) into NPPCs to engender a renascent phenotype and tuned the balance of extracellular matrix synthesis/catabolism in vitro and in vivo. Moreover, an intradiscal injectable hydrogel system that scavenges chemokines (MCP1 and IL8) in tandem with NPPCs rejuvenated NT‐LNPs in the IVD, modulating the inflammatory environment and synergistically promoting the regeneration of degenerated intervertebral discs. In summary, the findings establish that NPPCs can be re‐engineered to be youthful and pluripotent to maintain homeostasis and rejuvenation, thereby providing a reversible treatment strategy for IVDD with broad application in other senescence‐related diseases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Spine and Intervertebral Disc Pathology · Scoliosis diagnosis and treatment · Medical Imaging and Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedics Qilu Hospital Shandong Key Laboratory of Targeted Drug Delivery and Advanced Pharmaceutics NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education) Department of Pharmaceutics School of Pharmaceutical Sciences Cheeloo College of Medicine Shandong University 44 Cultural West Road Jinan Shandong 250012 China

Department of Neurosurgery Qilu Hospital and Institute of Brain and Brain‐Inspired Science Cheeloo College of Medicine Shandong University 107 Wenhua Xi Road Jinan Shandong 250012 China

Department of Chemical and Biological Engineering Hong Kong University of Science and Technology 4572A Academic Building Clear Water Bay Kowloon Hong Kong 999077 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · Shandong Provincial Postdoctoral Science Foundation

References (46)

Show source-provided references
1. 10.1016/S0140-6736(18)30488-410.1016/S0140-6736(18)30488-4 ↗
2. 10.1007/s11916-019-0757-110.1007/s11916-019-0757-1 ↗
3. 10.1016/S0140-6736(21)00733-910.1016/S0140-6736(21)00733-9 ↗
4. 10.1016/S0140-6736(18)30489-610.1016/S0140-6736(18)30489-6 ↗
5. 10.1056/NEJMcp151265810.1056/NEJMcp1512658 ↗
6. 10.1126/scitranslmed.adf169010.1126/scitranslmed.adf1690 ↗
7. 10.1038/s41580-022-00510-w10.1038/s41580-022-00510-w ↗
8. 10.1038/ncomms222610.1038/ncomms2226 ↗
9. 10.1038/s41556-019-0417-z10.1038/s41556-019-0417-z ↗
10. 10.1101/gad.9.10.123710.1101/gad.9.10.1237 ↗
11. 10.1038/s41413-021-00163-z10.1038/s41413-021-00163-z ↗
12. 10.1016/j.isci.2023.10669210.1016/j.isci.2023.106692 ↗
13. 10.1038/s43587-021-00143-210.1038/s43587-021-00143-2 ↗
14. 10.1038/s41392-022-00957-510.1038/s41392-022-00957-5 ↗
15. 10.1186/ar383010.1186/ar3830 ↗
16. 10.1016/j.mad.2022.11171510.1016/j.mad.2022.111715 ↗
17. 10.1038/ncomms1250310.1038/ncomms12503 ↗
18. 10.1046/j.1524-475X.1997.50405.x10.1046/j.1524-475X.1997.50405.x ↗
19. 10.1038/nrrheum.2013.16010.1038/nrrheum.2013.160 ↗
20. Jiang G. J. · Sci. Transl. Med. · 2023 · 15 · 1
21. 10.1126/scitranslmed.adg702010.1126/scitranslmed.adg7020 ↗
22. 10.1038/s41587-020-0591-310.1038/s41587-020-0591-3 ↗
23. 10.1038/s41586-018-0414-610.1038/s41586-018-0414-6 ↗
24. 10.1016/j.matbio.2020.09.00310.1016/j.matbio.2020.09.003 ↗
25. 10.1016/j.biomaterials.2012.06.08810.1016/j.biomaterials.2012.06.088 ↗
26. 10.1111/bjd.1782410.1111/bjd.17824 ↗
27. 10.1016/j.celrep.2017.10.05710.1016/j.celrep.2017.10.057 ↗
28. 10.4161/cc.7.21.701210.4161/cc.7.21.7012 ↗
29. 10.1016/j.matbio.2018.03.01910.1016/j.matbio.2018.03.019 ↗
30. 10.1371/journal.pone.009844410.1371/journal.pone.0098444 ↗
31. 10.1007/s11033-018-4260-210.1007/s11033-018-4260-2 ↗
32. 10.3390/ijms2007176710.3390/ijms20071767 ↗
33. 10.1016/j.intimp.2020.10668110.1016/j.intimp.2020.106681 ↗
34. 10.3389/fimmu.2022.91799810.3389/fimmu.2022.917998 ↗
35. 10.4161/cc.8.16.936710.4161/cc.8.16.9367 ↗
36. 10.1038/cr.2016.410.1038/cr.2016.4 ↗
37. 10.1038/s41581-018-0078-310.1038/s41581-018-0078-3 ↗
38. 10.1038/nrc396010.1038/nrc3960 ↗
39. 10.3389/fcell.2021.79697410.3389/fcell.2021.796974 ↗
40. 10.1002/jor.2363710.1002/jor.23637 ↗
41. 10.1126/scitranslmed.aay238010.1126/scitranslmed.aay2380 ↗
42. 10.1016/j.jmbbm.2019.03.02410.1016/j.jmbbm.2019.03.024 ↗
43. 10.1126/scitranslmed.aau067010.1126/scitranslmed.aau0670 ↗
44. 10.1080/03008207.2019.161179310.1080/03008207.2019.1611793 ↗
45. 10.1002/advs.20190209910.1002/advs.201902099 ↗
46. 10.1016/j.cej.2020.12736210.1016/j.cej.2020.127362 ↗